{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:46:33Z","timestamp":1697237193597},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1007\/s11894-002-0025-z","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T20:12:29Z","timestamp":1179605549000},"page":"490-496","source":"Crossref","is-referenced-by-count":12,"title":["Assessing disease activity and disease activity indices for inflammatory bowel disease"],"prefix":"10.1007","volume":"4","author":[{"given":"Feng Xiao","family":"Li","sequence":"first","affiliation":[]},{"given":"Lloyd R.","family":"Sutherland","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"25_CR1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0016-5085(79)90383-4","volume":"77","author":"DH Winship","year":"1979","unstructured":"Winship DH, Summers RW, Singleton JW, et al.: National Cooperative Crohn\u2019s Disease Study: study design and conduct of the study. Gastroenterology 1979, 77:829\u2013842.","journal-title":"Gastroenterology"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology 1976, 70:439\u2013444. Classic reference initiating the CDAI.","journal-title":"Gastroenterology"},{"key":"25_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et al.: A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn\u2019s disease. Gastroenterology 2002, 122:512\u2013530. The current definitive review of activity indices in IBD.","journal-title":"Gastroenterology"},{"key":"25_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/gut.28.4.474","volume":"28","author":"Dombal FT de","year":"1987","unstructured":"de Dombal FT, Softley A: IOIBD Report no 1: Observer variation in calculating indices of severity and activity in Crohn\u2019s disease. International Organisation for the Study of Inflammatory Bowel Disease. Gut 1987, 28:474\u2013481.","journal-title":"Gut"},{"key":"25_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM: A simple index of Crohn\u2019s-disease activity. Lancet 1980, 1:514.","journal-title":"Lancet"},{"key":"25_CR6","first-page":"111","volume":"144","author":"J Myren","year":"1988","unstructured":"Myren J, Bouchier IA, Watkinson G, et al.: The OMGE multinational inflammatory bowel disease survey 1976\u20131986: a further report on 3175 cases. Scand J Gastroenterol 1988, 144 (Suppl):111\u2013119.","journal-title":"Scand J Gastroenterol"},{"key":"25_CR7","first-page":"502","volume":"68","author":"JP Wright","year":"1985","unstructured":"Wright JP, Marks IN, Parfitt A: A simple clinical index of Crohn\u2019s disease activity: the Cape Town index. S Afr Med J 1985, 68:502\u2013503.","journal-title":"S Afr Med J"},{"key":"25_CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/gut.21.4.279","volume":"21","author":"PA Hees van","year":"1980","unstructured":"van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JH: An index of inflammatory activity in patients with Crohn\u2019s disease. Gut 1980, 21:279\u2013286.","journal-title":"Gut"},{"key":"25_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ: Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995, 20:27\u201332.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, et al.: Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 1999, 340:1398\u20131405.","journal-title":"N Engl J Med"},{"key":"25_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0895-4356(88)90046-7","volume":"41","author":"RS Sandler","year":"1988","unstructured":"Sandler RS, Jordan MC, Kupper LL: Development of a Crohn\u2019s index for survey research. J Clin Epidemiol 1988, 41:451\u2013458.","journal-title":"J Clin Epidemiol"},{"key":"25_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","volume":"12","author":"JS Hyams","year":"1991","unstructured":"Hyams JS, Ferry GD, Mandel FS, et al.: Development and validation of a pediatric Crohn\u2019s disease activity index. J Pediatr Gastroenterol Nutr 1991, 12:439\u2013447.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ: Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955, 2:1041\u20131048.","journal-title":"BMJ"},{"key":"25_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01296733","volume":"27","author":"J Powell-Tuck","year":"1982","unstructured":"Powell-Tuck J, Day DW, Buckell NA, et al.: Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982, 27:533\u2013537.","journal-title":"Dig Dis Sci"},{"key":"25_CR15","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987, 317:1625\u20131629.","journal-title":"N Engl J Med"},{"key":"25_CR16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","volume":"92","author":"LR Sutherland","year":"1987","unstructured":"Sutherland LR, Martin F, Greer S, et al.: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92:1894\u20131898.","journal-title":"Gastroenterology"},{"key":"25_CR17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989, 298:82\u201386.","journal-title":"BMJ"},{"key":"25_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","volume":"106","author":"EJ Irvine","year":"1994","unstructured":"Irvine EJ, Feagan B, Rochon J, et al.: Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn\u2019s Relapse Prevention Trial Study Group. Gastroenterology 1994, 106:287\u201396. Important early reference incorporating quality of life into IBD assessment.","journal-title":"Gastroenterology"},{"key":"25_CR19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","volume":"96","author":"G Guyatt","year":"1989","unstructured":"Guyatt G, Mitchell A, Irvine EJ, et al.: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804\u2013810.","journal-title":"Gastroenterology"},{"key":"25_CR20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","volume":"342","author":"BG Feagan","year":"2000","unstructured":"Feagan BG, Fedorak RN, Irvine EJ, et al.: A comparison of methotrexate with placebo for the maintenance of remission in Crohn\u2019s disease. North American Crohn\u2019s Study Group Investigators. N Engl J Med 2000, 342:1627\u20131632.","journal-title":"N Engl J Med"},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199409293311303","volume":"331","author":"GR Greenberg","year":"1994","unstructured":"Greenberg GR, Feagan BG, Martin F, et al.: Oral budesonide for active Crohn\u2019s disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med 1994, 331:836\u2013841.","journal-title":"N Engl J Med"},{"key":"25_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/gast.1996.v110.pm8536887","volume":"110","author":"GR Greenberg","year":"1996","unstructured":"Greenberg GR, Feagan BG, Martin F, et al.: Oral budesonide as maintenance treatment for Crohn\u2019s disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996, 110:45\u201351.","journal-title":"Gastroenterology"},{"key":"25_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/BF01538073","volume":"34","author":"DA Drossman","year":"1989","unstructured":"Drossman DA, Patrick DL, Mitchell CM, et al.: Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989, 34:1379\u20131386.","journal-title":"Dig Dis Sci"},{"key":"25_CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006842-199111000-00010","volume":"53","author":"DA Drossman","year":"1991","unstructured":"Drossman DA, Leserman J, Li ZM, et al.: The rating form of IBD patient concerns: a new measure of health status. Psychosom Med 1991, 53:701\u2013712.","journal-title":"Psychosom Med"},{"key":"25_CR25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3109\/00365529709028153","volume":"32","author":"H Hjortswang","year":"1997","unstructured":"Hjortswang H, Strom M, Almeida RT, Almer S: Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol 1997, 32:1235\u20131240. Another classic reference.","journal-title":"Scand J Gastroenterol"},{"key":"25_CR26","doi-asserted-by":"crossref","unstructured":"Reproducibility of colonoscopic findings in Crohn\u2019s disease: a prospective multicenter study of interobserver variation. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Dig Dis Sci 1987, 32:1370\u20131379.","DOI":"10.1007\/BF01296663"},{"key":"25_CR27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","volume":"98","author":"R Modigliani","year":"1990","unstructured":"Modigliani R, Mary JY, Simon JF, et al.: Clinical, biological, and endoscopic picture of attacks of Crohn\u2019s disease: evolution on prednisolone. Groupe d\u2019Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990, 98:811\u2013818. Important prospective endoscopic study that validated the CDEIS.","journal-title":"Gastroenterology"},{"key":"25_CR28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","volume":"30","author":"JY Mary","year":"1989","unstructured":"Mary JY, Modigliani R: Development and validation of an endoscopic index of the severity for Crohn\u2019s disease: a prospective multicentre study. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989, 30:983\u2013989.","journal-title":"Gut"},{"key":"25_CR29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","volume":"116","author":"G D\u2019Haens","year":"1999","unstructured":"D\u2019Haens G, Van Deventer S, et al.: Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn\u2019s disease: a European multicenter trial. Gastroenterology 1999, 116:1029\u20131034.","journal-title":"Gastroenterology"},{"key":"25_CR30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0016-5085(92)91725-J","volume":"102","author":"B Landi","year":"1992","unstructured":"Landi B, Anh TN, Cortot A, et al.: Endoscopic monitoring of Crohn\u2019s disease treatment: a prospective, randomized clinical trial. The Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1992, 102:1647\u20131653.","journal-title":"Gastroenterology"},{"key":"25_CR31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, et al.: Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology 1990, 99:956\u2013963.","journal-title":"Gastroenterology"},{"key":"25_CR32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0016-5085(99)70125-3","volume":"116","author":"G Hellers","year":"1999","unstructured":"Hellers G, Cortot A, Jewell D, et al.: Oral budesonide for prevention of postsurgical recurrence in Crohn\u2019s disease. The IOIBD Budesonide Study Group. Gastroenterology 1999, 116:294\u2013300.","journal-title":"Gastroenterology"},{"key":"25_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.1994.tb00158.x","volume":"8","author":"R Caprilli","year":"1994","unstructured":"Caprilli R, Andreoli A, Capurso L, et al.: Oral mesalazine (5-aminosalicylic acid, Asacol) for the prevention of postoperative recurrence of Crohn\u2019s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994, 8:35\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00042737-199603000-00008","volume":"8","author":"C Florent","year":"1996","unstructured":"Florent C, Cortot A, Quandale P, et al.: Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn\u2019s disease. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996, 8:229\u2013233.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"25_CR35","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts P, Hiele M, Geboes K, et al.: Controlled trial of metronidazole treatment for prevention of Crohn\u2019s recurrence after ileal resection. Gastroenterology 1995, 108:1617\u20131621.","journal-title":"Gastroenterology"},{"key":"25_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","volume":"1","author":"JH Baron","year":"1964","unstructured":"Baron JH, Connell AM, Lennard-Jones JE: Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964, 1:89\u201392.","journal-title":"BMJ"},{"key":"25_CR37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"GR D\u2019Haens","year":"1998","unstructured":"D\u2019Haens GR, Geboes K, Peeters M, et al.: Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998, 114:262\u2013267.","journal-title":"Gastroenterology"},{"key":"25_CR38","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","volume":"1","author":"SC Truelove","year":"1956","unstructured":"Truelove SC, Richards WCD: Biopsy studies in ulcerative colitis. BMJ 1956, 1:1315\u20131318.","journal-title":"BMJ"},{"key":"25_CR39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1994.tb00340.x","volume":"8","author":"R Lofberg","year":"1994","unstructured":"Lofberg R, Ostergaard Thomsen O, et al.: Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1994, 8:623\u2013629.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR40","first-page":"18","volume":"35","author":"CJ Mulder","year":"1989","unstructured":"Mulder CJ, Endert E, van der Heide H, et al.: Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis: an adrenocortical approach. Neth J Med 1989, 35:18\u201324.","journal-title":"Neth J Med"},{"key":"25_CR41","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0016-5085(94)90394-8","volume":"106","author":"WJ Sandborn","year":"1994","unstructured":"Sandborn WJ, Tremaine WJ, Schroeder KW, et al.: A placebocontrolled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 1994, 106:1429\u20131435.","journal-title":"Gastroenterology"},{"key":"25_CR42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01297104","volume":"32","author":"JP Wright","year":"1987","unstructured":"Wright JP, Young GO, Tigler-Wybrandi N: Predictors of acute relapse of Crohn\u2019s disease: a laboratory and clinical study. Dig Dis Sci 1987, 32:164\u2013170.","journal-title":"Dig Dis Sci"},{"key":"25_CR43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0895-4356(96)00136-9","volume":"49","author":"EJ Irvine","year":"1996","unstructured":"Irvine EJ, Feagan BG, Wong CJ: Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol 1996, 49:1177\u20131185.","journal-title":"J Clin Epidemiol"},{"key":"25_CR44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0021-9681(87)90069-5","volume":"40","author":"G Guyatt","year":"1987","unstructured":"Guyatt G, Walter S, Norman G: Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987, 40:171\u2013178.","journal-title":"J Chronic Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-002-0025-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-002-0025-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-002-0025-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:34:54Z","timestamp":1587533694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-002-0025-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s11894-002-0025-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}